SCHEMBL13626600

SCHEMBL13626600

CCN(c1cc(OC)ccc1[C@H]1CCc2cc(O)ccc2C1)C(C)c1ccc(OCCN(C)C)cc1

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 3/20 0.51
ESR2 Q92731 2/20 0.51
DRD2 P14416 10/20 0.38
DRD3 P35462 10/20 0.38
CYP26A1 O43174 1/20 0.37
CHRNB2 P17787 1/20 0.34
CHRNA4 P43681 1/20 0.34
DRD4 P21917 5/20 0.34
HTR1A P08908 1/20 0.33
MEN1 O00255 1/20 0.33
ADRB2 P07550 1/20 0.33
CYP2D6 P10635 1/20 0.33
CASP1 P29466 1/20 0.33
KMT2A Q03164 1/20 0.33
SLC6A4 P31645 1/20 0.33
HRH3 Q9Y5N1 1/20 0.33
CA1 P00915 1/20 0.33
CA2 P00918 1/20 0.33
ACHE P22303 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13626588 1.00 ESR1 (0.51) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626598 0.94 ESR1 (0.49) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626589 0.94 ESR1 (0.51) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626666 0.92 ESR1 (0.42) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626575 0.90 ESR1 (0.54) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626574 0.89 ESR1 (0.53) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626578 0.88 ESR1 (0.54) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626576 0.88 ESR1 (0.52) ESR1ESR2DRD2DRD3CYP26A1
SCHEMBL13626590 0.88 ESR1 (0.48) ESR1ESR2DRD2DRD3SLC6A4
SCHEMBL13626591 0.88 ESR1 (0.48) ESR1ESR2DRD2DRD3SLC6A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7612114-B2 Such as (R)-6-{2-{ethyl[4-(2-ethylaminoethyl)benzyl]amino }-4-methoxyphenyl }-5,6,7,8-tetrahydronaphthalen-2-ol; osteoporosis; breast cancer EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-11-03 US disclosed